MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
77<br />
The “Invitation to jo<strong>in</strong> the PACE trial” leaflet builds on this same assertion: “Some patient surveys suggest CBT<br />
and GET can make symptoms worse – but experts (ie. the Wessely School themselves, who portray themselves<br />
as world‐class experts <strong>in</strong> “CFS”) believe this happens when the therapy is not used properly or when there isn’t good<br />
professional supervision”.<br />
An editorial by Peter White et al <strong>in</strong> the British Medical Journal just after the NICE Guidel<strong>in</strong>e on “CFS/<strong>ME</strong>”<br />
was published (BMJ 2007: 335:411‐412) further promoted this belief, claim<strong>in</strong>g that: “effective treatments are<br />
available” and, quot<strong>in</strong>g the NICE Guidel<strong>in</strong>e, CBT and GET “show ‘the clearest research evidence of benefit’”.<br />
White also cited what he claimed were two patient surveys carried out by Action for <strong>ME</strong>, one <strong>in</strong> 2001 (see<br />
above) and the other <strong>in</strong> 2004 (“All about <strong>ME</strong>: an <strong>in</strong>troduction”). The latter reference <strong>in</strong> the BMJ appears to be<br />
<strong>in</strong>correct, because it is not a survey; it is an Af<strong>ME</strong> booklet that simply says about GET (on page 19): “Surveys<br />
carried out by Action for M.E. suggest that graded activity / exercise can be harmful when misapplied”. It seems that<br />
Peter White may have meant to cite the 2003 Af<strong>ME</strong> survey (reference 15 <strong>in</strong> the published version of the<br />
Protocol) when he asserted that the later survey “showed that this was related to <strong>in</strong>appropriate advice or lack of<br />
therapeutic support”, a declarative but unsupportable sentence, s<strong>in</strong>ce an analysis of Af<strong>ME</strong>’s 2003 survey data<br />
reveals no supportive data for Peter White’s assertion.<br />
Furthermore, White seems amnesic about his own 1997 study referred to above (BMJ 1997:314:1647‐1652)<br />
which was categoric: “If patients compla<strong>in</strong>ed of <strong>in</strong>creased fatigue they were advised to cont<strong>in</strong>ue at the same<br />
level of exercise”, which clearly disproves his claim that previous adverse events occurred “when the<br />
therapy is not used properly or when there isn’t good professional supervision”.<br />
The short (published) version of the PACE Trial protocol states: “We will also carefully monitor all participants<br />
for any adverse effects of the treatments”. If there is a need to monitor participants carefully, then there must be<br />
possible risks and participants were entitled to know about them and the researchers were obliged to <strong>in</strong>form<br />
participants of those risks. The 2003 survey by Af<strong>ME</strong> appears to be used as justification for not tak<strong>in</strong>g the<br />
risks associated with GET seriously enough. Quite how the unsubstantiated suggestion of a charity that<br />
bears no responsibility for the safety of research participants is deemed to support the safety of the MRC<br />
PACE Trial GET participants is not made clear.<br />
An e‐BMJ response by <strong>ME</strong> advocate Annette Barclay (http://www.bmj.com/cgi/eletters/335/7617/411#176155)<br />
showed that what Peter White asserted did not withstand scrut<strong>in</strong>y: “I was disappo<strong>in</strong>ted to see Peter White et al<br />
try<strong>in</strong>g to put a ‘sp<strong>in</strong>’ on a patient survey to cover up the very poor success rate of GET. The data from the second<br />
survey mentioned simply doesn’t back up their claims. White et al said that the GET failures reported <strong>in</strong> the first<br />
survey were down to ‘<strong>in</strong>appropriate advice or lack of therapeutic support’. However, the survey shows that the 2 nd<br />
group who reported positive experience with GET were the group who had NO professional help at all. This shows<br />
White’s argument about ‘<strong>in</strong>appropriate advice or lack of therapeutic support’ to be without foundation”. Annette<br />
Barclay also po<strong>in</strong>ted out that Dr Lesley Cooper’s 2000 survey reported that GET made people worse or was<br />
unhelpful <strong>in</strong> 61.3% of cases, and that the second survey carried out by Af<strong>ME</strong> <strong>in</strong>correctly referenced by Peter<br />
White <strong>in</strong> the BMJ did not use an <strong>in</strong>dependent survey company and did not ask the same questions as the<br />
earlier survey, yet of the 54 people who had undergone GET, 59% said that GET was either a negative or<br />
neutral experience. Her response cont<strong>in</strong>ued: “Af<strong>ME</strong> did not ask how well people undergo<strong>in</strong>g GET were supported<br />
by professionals <strong>in</strong>volved and what difference this support made. They were not asked about ‘<strong>in</strong>appropriate advice’. It’s<br />
wrong of White to blame GET failures on these factors, rather than GET itself for people with <strong>ME</strong>”. Annette Barclay<br />
then delivered her punch l<strong>in</strong>e, po<strong>in</strong>t<strong>in</strong>g out that the second Af<strong>ME</strong> (2003) survey found that: “the worst type of<br />
professional for a person with <strong>ME</strong> to see was an Occupational Therapist, a Physiotherapist, or at a Gym. ALL the<br />
respondents who tried GET with an Occupational Therapist or at a Gym reported a negative experience. The Physios<br />
had more mixed results but many negatives….To sum up, the data does not support the sp<strong>in</strong> given by White et al <strong>in</strong><br />
their editorial. From the second survey, we know that the majority had a ‘negative’ or ‘neutral’ effect and that these<br />
were treated by professionals – the very people we rely on to give us ‘appropriate advice and therapeutic support’“.<br />
As Tom K<strong>in</strong>dlon po<strong>in</strong>ted out on Co‐Cure ACT on 11 th September 2009, the large Af<strong>ME</strong> 2008 survey (see<br />
above) found that there was no significant difference between the number of adverse reactions suffered by